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A B S T R A C T
Klebsiella pneumoniae is an important human pathogen that is considered in recent years due to nosocomial
infections resistant to treatment as well as the ability to form bioﬁlms particularly in patients with urinary tract
infection in ICU or hospital. The aim of this study was to evaluate the prevalence of VIM1, IMP1 genes and their
ability to form bioﬁlm in K. pneumoniae strains isolated from patients with urinary tract infection. In the study,
using culture and biochemical methods, 1807 K. pneumoniae samples were isolated from patients with urinary
tract infection hospitalized or referred to hospitals in Qom in 2013–2014. For isolation of MBL producing iso-
lates, Double Disk Synergy Test (DDST) was used. Then MBL positive isolates were examined for the presence of
VIM1, IMP1 genes using PCR method. Furthermore, all strains were investigated for bioﬁlm formation by
phenotypic microplate method. From 3165 urine samples cultured, 1807 isolates of K. pneumoniae were isolated
and 109 strains (93.2%) were positive for MBL enzymes production. PCR results showed that the prevalence of
VIM1 and IMP1 genes are 15.6 and 6.4%, respectively. The Phenotypic method indicated that 91.2% of isolates
formed bioﬁlm. Bioﬁlm formation in K. pneumoniae isolates is high and there is a signiﬁcant relationship be-
tween strong bioﬁlm formation and prevalence of VIM1 and IMP1 genes. Also due to the presence of MBL genes
in K. pneumoniae and horizontal transfer of genes to other bacteria, and to control the indiscriminate use of
antibiotics, the hospital infection control methods must be considered.
1. Introduction
Klebsiella pneumoniae is a Gram-negative bacilli that belongs to the
Enterobacteriaceae family, which are part of the natural microﬂora of
the human gut that can cause infections such as cystitis, pyelonephritis,
septicemia, pneumonia, peritonitis, meningitis, diarrhea, osteomyelitis,
and ulcers infections [1]. These bacteria can easily spread among
people as nosocomial infections [2]. Urinary tract infection is a one of
the largest bacterial infection that occurs in the community and in the
hospital [3]. It is estimated that urinary tract infection includes25-40%
of nosocomial infection [4] and each year more than 8.3 million people
see a physician due to urinary tract infection. The UTI infection of this
bacteria are seen in patients with urinary catheters, diabetes or im-
munosuppressed patients [5] and it is able to produce bioﬁlm. Bioﬁlms
are bacterial populations that are connected by exopolysaccharides
matrix on the surfaces. A matrix of extracellular polymeric substances
(EPS) essentially consists of polysaccharides, proteins, lipids and nu-
cleic acids in various amount. Moreover, Extracellular bioﬁlm matrix,
and oxygen gradient exist in bioﬁlm architecture prevents the action of
some antibiotics [6,7]. Bioﬁlm bacteria are more resistant to antibiotics
than other bacteria, so bioﬁlms are a major cause of resistance to an-
timicrobial substances. Some studies reported that more than 65% of
hospital-acquired infections are caused by bioﬁlm-producing strains
which are resistant infections with high healthcare costs. These bioﬁlm
infections are 10–1000 times more resistant to the eﬀects of anti-
microbial agents and antibiotics [6,7].
Klebsiella spp generates ﬁmbriae, which facilitate bacterial binding
to host mucosal surfaces and with capsules and can exhibit anti-pha-
gocytic activity. One and three pili-types of Klebsiella spp play a role in
the colonization of urinary tract infection. Organisms that are present in
the bioﬁlm use one or more mechanisms of drug resistance [8]. Bioﬁlm
formation ability in bacteria leads to chronic urinary tract infections
[8]. Bioﬁlms physically protect bacteria against the host immune
system and antibiotics. This phenomenon is one of the causes of in-
fections disease recurrence [9]. Eighty percent of infections are asso-
ciated with the use of urinary catheters where K. pneumoniae plays an
important role in the formation of bioﬁlm on urinary catheters [10].
Increase in antibiotic resistance among Enterobacteriaceae family is a
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cause of major concern. Beta-lactam is an important antibiotic for the
treatment of K. pneumoniae infections, but multidrug-resistant strains of
ESBL producing strains in recent decades, have caused severe infec-
tions, which are resistant to treatment and even lead to death [6].
Carbapenem is the most eﬀective drug for the treatment of ESBL
producing K. pneumoniae infections. However, clinical use of carbape-
nema reaﬀected by carbapenemase enzymes produced by resistant
bacteria (basically MBLs). These enzymes (MBLs) have been reported in
many parts of the world and have very high resistance to all beta-lac-
tams except aztreonam [11].
Class B of lactamases includes VIM (Verona integron-encoded me-
tallo-β-lactamase) and IMP (Imipenemase) and most recently (New
Delhi metallo-β-lactamase-1) NDM-1. These enzymes are able to hy-
drolyze penicillins, cephalosporins, Monobactams and carbapenems
except aztreonam [12].
The aim of this study is to examine the relationship between bio-
ﬁlms and the presence of carbapenem resistance genes (VIM and IMP).
2. Materials and methods
2.1. Isolation and identiﬁcation
In this study, K. pneumoniae were isolated from patients with ur-
inary tract infection referred to Shahid Beheshti, Nekoyi, Kamkar, Vali
Asr and Gulpaigani hospitals of Qom between 2013 and 2014. Out of
3165 urine samples, 1807 cultured plates were positive and bacteria
were isolated as described in (Fig. 1). Patients with WBC ≥5/hpf and
≥104 CFU/ml in urine cultures were selected for this study.
For this purpose, Midstream Specimen of Urine was taken for cul-
tivation and were incubated for 18 to 24 h on conventional micro-
biology environments such as eosin methylene blue, MacConkey and
blood agar at 37 °C. Identiﬁcation of K. pneumoniae and other factors
causing urinary infection was done by microbiological methods, in-
cluding Gram stain, biochemical tests such as oxidase, catalase, IMVIC
and urease test. The bacteria isolated were examined by API20E kit for
ﬁnal approval (Fig. 2).
2.2. MBL-producing strain identiﬁcation
Imipenem-resistant strains were identiﬁed by antibiotic suscept-
ibility test using Kirby-Bauer disk diﬀusion method on Mueller-Hinton
agar (Merck, Germany) and 10 μg imipenem disc (MAST, England)
according to CLSI 2013 instructions. E. coli ATCC25922 strain and K.
pneumoniae ATCC 700603 strain were used as a negative and positive
control, respectively.
Strains resistant to imipenem were used to identify MBL-producing
strains using DDST (Double disk synergy test) on Mueller Hinton agar
medium. For this purpose, a 10 μg imipenem disc alone and an imi-
penem disk with 10 μl EDTA (0.5mM) at distance of 20mm were used
on Mueller-Hinton agar. After 18 h of incubation at 37 °C inhibition
zone of imipenem alone, they were compared with imipenem and
EDTA. An increase of 7mm or more on imipenem and EDTA compared
to imipenem alone indicated the presence of MBL indicating that the
test is positive [13].
2.3. Identifying the bioﬁlm forming strains
For testing bioﬁlm formation, using phenotypic microplate, isolates
were incubated in Luria broth (LB) at 37°Cfor 18 h. Then 200 μl of TSB
was transferred to every well of sterile microplate (96 cells), then 10 μl
of bacterial suspension of incubated isolates (24 h) at opacity of half
McFarland was added into the wells and was incubated at 37 °C for 24 h
and then discharged from the wells and was washed 3 times with saline
to keep the plate completely dry.
Then 200 μl of 1% crystal violet was poured for 20min into the
wells and was washed 3 times with saline and dried. Finally, 200 μl of
DMSO was added to each well and the plate was examined by ELISA
Plate Reader at 595 nm wavelength. High absorption is indicative of
bioﬁlm formation. Each test was repeated three times [14].
The ability to produce bioﬁlm was considered in four categories:
Group 1: strong bioﬁlm OD > 0.5.
Group 2: middle bioﬁlm 0.5 > OD > 0.3.
Group 3: weak bioﬁlm OD < 0.3.
Group 4: Lack of bioﬁlm OD < 0.15.
To control the test, an environment without adding bacterial sus-
pension was used as a negative control. Samples that generated bioﬁlm
phenotypically were examined in terms of Photo Electron FE-SEM
(Field Emission Scanning Electron Microscopy.
2.4. PCR reactions and identiﬁcation of VIM and EMP genes
DNA extraction was done by PP-214SBacteria Genomic DNA
Extraction Kit (BioNeer Korea). PCR reaction was considered at 25 μl
ﬁnal volume containing 0.2 mM of each dNTP (dATP, dCTP, dGTP,
dTTP), 10 mMTris-HCl (pH 8.3), 50 mM KCl, 1.5mMMgCl2 and 1U Top
DNA polymerase. Table 1 shows the sequence of used primers and PCR
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Fig. 1. The percentage of bacteria isolated from urine samples from
hospitals in Qom during 2014–2015.
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2.5. Electrophoresis of PCR products
PCR products undergone electrophoresis on 1.5% agarose gel.
Agarose gel was stained with ethidium bromide and was photographed
by UV trans-illuminator (INGENIUS, SYN GENE). A DNA 100bpladder
(BioNeer, Korea) was used as the size of marker.
2.6. Data analysis and statistical analysis
For plotting of graphs, Excel was used. Statistical analysis was
performed with SPSS version 18.0 software (SPSS Inc. Chicago, IL,
USA). To study the presence of VIM-1 and IMP-1 genes and bioﬁlm
formation chi-square test was used. P-value< .05 were considered as
statistically signiﬁcant.
3. Result
This cross-sectional study was performed on urine samples collected
from hospitalized patients as well as outpatient suspected of K. pneu-
moniae in Shahid Beheshti, Kamkar, Nekoyi, Gulpaygani and Valiasr
hospitals in Qom during the one-year period from January 2014 to
January 2015.
During January 2014 to January 2015, 3165 urine samples were
cultured and 57.1% or 1807 samples were positive. Out of 1807 urine
samples, 993 E. coli, 457 K. pneumoniae, 112 Pseudomonas spp, 93
Enterobacter spp, 83 Proteus spp, 38 Klebsiella oxytoca and 31 Citrobacter
spp samples were separated (Fig. 1).
From 457 K. pneumoniae isolates, 259 samples (56.7%) were pa-
tients who were hospitalized two or more days in the hospital with no
symptoms of infection with K. pneumoniae in the initial hospitalization
and 198 samples (43.3%) were outpatient. The largest and the smallest
number of isolates of K. pneumoniae which are related to ICU and CCU
respectively, are shown in Table 2.
The urinary tract infections in women were 286 cases (62.6%) and
171 cases were seen in men (37.4%). The age range of patients was
1–89 years. The average age of women and men were 41.95 and
37.96years, respectively.
In examining the frequency of MBL enzymes of K. pneumoniae iso-
lates by phenotype method, 117 of 457 K. pneumoniae isolates (25.6%)
were resistant to imipenem and 109 cases (93.2%) were positive in
terms of MBL enzymes in Double Disk Synergy Test (imipenem disk
alone and imipenem with- EDTAFig. 3).
PCR results showed that VIM gene frequency is 17 (15.6%) and
VIM-1 gene electrophoresis gel image is shown in (Fig. 4). The fre-
quency of the IMP gene is 7 (6.4%) and IMP-1 gene electrophoresis gel
image is shown in (Fig. 5).
Using phenotype microplate method, bioﬁlm formation showed that
417 isolates of K. pneumoniae (91.2%) have formed bioﬁlm (Fig. 6) and
samples that generated bioﬁlm phenotypically were examined in terms
of Photo Electron FE-SEM (Field Emission Scanning Electron Micro-
scopy (Fig. 7).
The Relationship between bioﬁlm formation and MBL genes are
Fig. 2. API test results to conﬁrm the identiﬁcation of the isolates of K. pneumoniae.
Table 1
Primers for Ampliﬁcation of Genes From K. pneumoniae isolates.
Primer Name Primer Sequence (5′ to 3′) Cycle Initial Denaturation Cycling Final Extension Length (bp)
IMP-1 F:AAAAAAGACGGTAAGGTTCAAGC 33 5min, 94 °C 30 s, 95 °C; 30 s,56.9 °C; 1 min,72 °C 7min, 72 °C 260
R:ACCAGTTTTGCCTTACCATATTTG
VIM-1 F:CAAGTCCGTTAGCCCATTCC 33 5min, 94 °C 30 s, 95 °C; 30 sec,58 °C; 1 min,72 °C 10min, 72 °C 539
R:GGCACAACCACCGTATAGCAC
Table 2





Obstetrics and Gynecology 32 10.3
CCU 17 5.5
Fig. 3. MBL-producing K. pneumoniae. The right one is imipenem and the left is imipenem
and EDTA. An increase of 7 mm or more in the zone of inhibition as compared with
imipenem-EDTA and imipenem alone indicates the positivity of test and the presence of
MBL.
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summarized in Table 3 and Fig. 8.
The relationship between the ability to form bioﬁlm and MBL genes
are summarized in (Table 3). There is a signiﬁcant relationship between
presence of VIM and IMP genes and bioﬁlm formation (chi-square test
[P value< .05]).
4. Discussion
K. pneumoniae causes 5 to 7.5% of all nosocomial infections and is
one of four common pathogens in the intensive care unit [15–17].
Replacement, growth, and reproduction of pathogens in the kidneys,
bladder, and urinary tract is called UTI or (Urinary Tract Infection). In
this infection, there are clinical symptoms such as dysuria, urinary
frequency, pain and sometimes fever [18].
Urinary tract infections are one of the problems millions of people
are facing. The most common type of urinary tract infection is
asymptomatic bacteriuria. In the world, 150 million people suﬀer from
urinary tract infection annually [19].
Epidemiological studies have shown that urinary tract infections are
not limited to a speciﬁc age, but can also be seen in all age groups
including infants, children and adults. The prevalence of this infection
in women is 10 times more than men [20,21].
The presence of beta-lactamase genes such as TEM, SHV, CTX in the
bacteria led to resistance to beta-lactams (penicillins and cephalos-
porins), but today, the presence of carbapenem resistance genes in these
bacteria is important. Carbapenemase-producing Enterobacteriaceae
(CPE) have a potential for severe infections resistant to conventional
treatment, because they are resistant to antimicrobial drugs. In the US,
KPC (Klebsiella Pneumoniae Carbapenemase) is the most common and
important resistance mechanism to carbapenem in Enterobacteriaceae,
while MBLs such as VIM, IMP and NDM are more common in Asia [22].
Another problem that makes Klebsiella spp to be an important pa-
thogen that causes urinary tract infection is the formation of bioﬁlm.
One and three pili-types a role in the colonization of urinary tract in-
fection [23]. Bioﬁlms are bacteria mass connection that have the ability
to accumulate and bind to the surface. This causes more bacterial
Fig. 4. PCR product for detection of VIM-1 gene in K. pneumoniae. Lane1: DNA ladder
100bp: Lane2: negative control (E.coli [ATCC25922 ]). Lane3: positive control
(K.pneumoniae [ATCC 700603]): Lane 4 and 5: samples with VIM-1gene.
Fig. 5. PCR product for detection of IMP-1 gene in K. pneumoniae. Lane1:DNA ladder
100bp Lane2: positive control (K.pneumoniae [ATCC 700603]): Lane 3 and 4: samples
with IMP-1 gene: Lane5: negative control (E.coli [ATCC25922 ]).
Fig. 6. Image of microplate in phenotype microplate method bioﬁlm formation with
crystal violet stain.
Fig. 7. Image of electronic microscopy (FE-SEM) of K. pneumoniae. formed bioﬁlm.
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resistance to antimicrobial agents and low permeability of drugs to
bioﬁlm layer leads to their ineﬀectiveness [24]. On another hand, One
of the most important antibiotic tolerance mechanisms in bioﬁlm is a
slow growth rate of bacteria deactivates cell wall targeting antibiotics
which need fast growth. Moreover, Extracellular bioﬁlm matrix and
oxygen gradient exist in bioﬁlm architecture prevents the action of
some antibiotics. In addition, persister cells, that is dormant cells have
altered metabolism and can survive antimicrobial treatment [25,26].
In this study, from total urine samples,57.1% was positive and K.
pneumoniae prevalence was 25.3%, which is in line with a study in India
in 2013 [27]. However, it is lower compared to the study in Sao Paulo,
Brazil in 2015 [28] and a study in Nigeria (2015) (32.4%) [29].
The results of the study regarding the resistance to imipenem are in
line with the studies accomplished in Shahrekord [30], Zanjan [31] and
a study in Brazil in 2015 [28]. However, the resistance is higher com-
pared with one study in India in 2013 [27] and in Hamadan [32], which
seems to be due to diﬀerences in geographic location and pattern of
antibiotic use.
In terms of MBL enzymes, this study (93.2%) is close to a study in
2015 in India [33], but it was higher compared to a study in 2014 in
Malaysia [34] and Nigeria [35] as well as a study performed in 2007
in Kerman [36]. It could be due to genetic diﬀerences between strains
in diﬀerent regions.
VIM genes prevalence in this study was 15.6% which matched the
results achieved in India in 2013 [4] as well as the study published in
2009 in the US [37], but it was higher compared to a study in Nigeria in
2015 [29] and one study in 2010 [32] in Hamadan which may be due to
genetic diﬀerences between the strains and increase in resistance genes.
In terms of bioﬁlm formation in K. pneumoniae isolates, this study
matched the results of the US in 2013 [38] and India (2012) [14], as
well as the other study, was conducted in 2013 [38]. In terms of cor-
relation between MBL genes and bioﬁlm formation, no similar study has
been done so far, and in this study, there was a signiﬁcant relationship
between VIM and IMP and bioﬁlm formation.
5. Conclusion
The results of this study showed that the prevalence of MBL-pro-
ducing K. pneumoniae in patients in hospitals in Qom is high (93.2%).
Given that MBL-producing strains can become resistant to all beta-
lactam antibiotics, attention to urinary tract infection (UTI) is of no-
ticeable issue. Therefore, identiﬁcation of K. pneumoniae which is cap-
able of producing MBL was essential and can help physicians in pre-
scriotion of antibiotics for the treatment of patients with infections
caused by these bacteria.
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